Alfuzosin: all 35 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed ConditionsNot yet recruitingNCT06316336Phase 1
- The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed ConditionsNot yet recruitingNCT06228339Phase 1
- Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal FunctionsCompletedNCT01834729Phase 2Results posted
- An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract SymptomsCompletedNCT00893113Phase 3Results posted
- The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH PatientsCompletedNCT00696761Phase 4Results posted
- Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic EtiologyCompletedNCT00576823Phase 3Results posted
- Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionCompletedNCT00549939Phase 3Results posted
- Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedNCT00103402Phase 3Results posted
- The Effects of α-adrenergic Receptor Antagonists on Choroid and PupilCompletedNCT03144596Phase 4
- Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male VolunteersCompletedNCT02266537Phase 1
- Benign Prostatic Hyperplasia in TaiwanCompletedNCT00941343Not applicable
- Evaluation of Symptom-specific Goal AchievementCompletedNCT00836823Phase 4
- Alfuzosin for Medical Expulsion Therapy of Ureteral StonesStatus unknownNCT00713739Phase 3
- Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)TerminatedNCT00688948Phase 2/3
- Once Daily Given Alfuzosin in the Treatment of BPHCompletedNCT00637715Phase 4
- Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic EtiologyCompletedNCT00629720Phase 3
- A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney StonesWithdrawnNCT00583258Not applicable
- Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality StudyCompletedNCT00575913Phase 4
- Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate HypertrophyCompletedNCT00542165Phase 4
- The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate ScoreCompletedNCT00540891Phase 3
- SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCompletedNCT00486785Phase 4
- Alfuzosin Hydrochloride to Relieve Ureteral Stent DiscomfortCompletedNCT00467467Phase 3
- ALF-STONE: Alfuzosin in Uretheric StonesTerminatedNCT00454402Phase 3
- Alfuzosin Versus Placebo in Acute Urinary RetentionTerminatedNCT00453908Phase 3
- Male Sexual Health Questionnaire (MSHQ) - Sexual Function StudyCompletedNCT00427882Phase 4
- Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic HyperplasiaCompletedNCT00409357Phase 2
- Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCompletedNCT00401661Phase 4
- Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic HyperplasiaCompletedNCT00399464Phase 3
- Use of Alfuzosin in Stone Treatment With ESWLWithdrawnNCT00388271Phase 3
- Alfuzosin for Treating Acute Urinary RetentionCompletedNCT00336921Phase 2
- ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPHCompletedNCT00290030Phase 3
- ALF-ONE : ALFuzosin ONcE DailyCompletedNCT00280605Phase 4
- Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)CompletedNCT00256399Not applicable
- Minimally Invasive Surgical Therapy for BPHTerminatedNCT00064649Phase 3
- Clinical Trial in Males With BPH (Enlarged Prostate)CompletedNCT00029822Phase 3